European Journal of Endocrinology

Papers
(The median citation count of European Journal of Endocrinology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?612
OC45 - IL-1β/CXCL12 axis drives the crosstalk between PanNET cells and adipocytes388
OC40 - Aldosterone/cortisol ratio as a new marker for diagnosing mild autonomous cortisol secretion (MACS). Investigating the effects of mild hypercortisolism on the renin-angiotensin-aldosterone syst174
P12 - Morning spot urine iodine-to-creatinine ratio as a surrogate for 24-hour iodine excretion in adult non-pregnant women145
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management141
Challenges estimating the effects of testosterone on health outcomes in transgender men: immortal time bias and other methodological concerns107
EndoCompass project: research roadmap for growth disorders96
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men90
Two-year clinical outcomes of microwave ablation for benign thyroid nodules: results from a multicenter study90
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock87
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co86
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis83
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment60
Primary adrenal insufficiency in patients with CPOX gene mutations60
Hemodynamic and microvascular abnormalities in P450 oxidoreductase deficiency: evidence for COX-dependent dysfunction58
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial57
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy53
Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis51
EndoCompass project: the place of endocrinology in European research funding—an analysis of Horizon 202050
Neuroendocrine tumors and pregnancy: the French PregNET study48
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study48
Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study47
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study46
When selection becomes selection bias44
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study43
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis39
Transcriptional comparison of testicular adrenal rest tumors with fetal and adult tissues38
OC05 - The clinical risk scores for Cushing’s Syndrome overlap with the phenotype of partial lipodystrophies37
AMH as part of the diagnostic PCOS workup in large epidemiological studies36
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis36
Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly35
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors33
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis33
Soluble alpha klotho—impact of biological variables and reference intervals for adults32
European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group32
Cardiovascular risk in Danish transgender persons: a matched historical cohort study32
Bone strain index for fracture risk assessment in older men—the prospective STRAMBO study31
Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years31
Response to the letter: health outcomes of testosterone therapy in transgender men: methodological issues warrant caution31
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?30
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors30
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial30
Overdiagnosed and Oversupplemented: The Iatrogenic Rise of Vitamin D Toxicity30
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency29
Correction to: Recombinant human parathyroid hormone (1–84) is effective in CASR-associated hypoparathyroidism29
Physiological declines in sex steroid exposure in relation to changes in body composition in healthy men—a prospective cohort study29
Higher peak height velocity in early maturing girls depends on insulin rather than fat mass or IGF-I28
A simple fragility fracture risk score for type 2 diabetes patients: a derivation, validation, comparison, and risk stratification study28
Vaginal bleeding in women with ovarian neuroendocrine tumor metastases should not be overlooked27
Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer: a histopathological study27
Response to the letter from Massimo Giusti27
P44 - A strange case of primary amenorrhea26
Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury26
P32 - Transient 18F-FDG PET/CT uptake of contralateral adrenal gland in patient under mitotane for R0 corticosurrenaloma26
No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine26
Urea-stimulated copeptin: a novel diagnostic approach in polyuria polydipsia syndrome25
Healthcare cost and survival in patients with non-functioning pituitary adenoma25
P48 - Drug response profiling of adrenocortical carcinoma in vitro models reveals differential sensitivity to cisplatin and etoposide25
Serum and hair steroid profiles and their associations with body composition in adolescence24
Epidemiological and clinical data from the European Lipodystrophy Registry24
C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a single-center study of 159 fasting trials23
EndoCompass project: environmental endocrinology23
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects22
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease22
Thyroid strain in pregnancy: a nationwide study of iodine nutrition and thyroglobulin among Faroese pregnant women22
Familial central precocious puberty due to DLK1 deficiency: novel genetic findings and relevance of serum DLK1 levels22
Clinical features and growth harmone response in 25 children with duplications in the SHOX region21
Metaphyseal band fractures in pediatric patients treated with denosumab21
Early puberty suppression and gender-affirming hormones do not alter final height in transgender adolescents21
Diagnostic strategies for central adrenal insufficiency in clinical practice: authors’ response21
Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study21
Correction to: Long-term effects of primary hyperparathyroidism and parathyroidectomy on kidney function21
OC25 - Exploring miR-200 family expression in obesity20
Paraprotein-induced spurious hypercalcaemia: diagnostic pitfalls in two cases20
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study20
P33 - A rare case of thyroblastoma with atypical somatic mutations20
EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: My quarter century quest to understand the paradox of marrow adiposity20
Long-term antitumour effects of pasireotide in acromegaly20
Risk of depression in patients with acromegaly in Korea (2006-2016): a nationwide population-based study20
Impact of antiresorptive agents on mortality risk in postmenopausal women with osteoporosis: insights from a nationwide cohort study20
Uniparental disomy leads to a novel cause of MC2R-related familial glucocorticoid deficiency type 120
Pediatric reference charts of dual-energy X-ray absorptiometry body composition measures20
Exome findings in children with short stature evaluated by growth hormone stimulation testing20
Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study19
Growth hormone treatment adjusted for growth hormone sensitivity in idiopathic short stature19
Daily hassles and cortisol suppression following low-dose dexamethasone suppression test are independently associated with cardiovascular disease19
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma18
Severe symptomatic hyponatremia in Europe: insights into current clinical practice18
EndoCompass project: research roadmap for diabetes, obesity, and metabolism18
Incidence and hospital outcomes of acute adrenal crisis in a Swiss-wide cohort study18
Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis18
A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas17
Medical treatment in acromegaly: a network meta-analysis17
Denosumab withdrawal increases vertebral fracture and mortality risk compared with zoledronate17
Pituitary apoplexy in SARS-CoV-2 infected is not necessarily related to the virus17
Body image concerns in women with polycystic ovary syndrome: a systematic review and meta-analysis17
Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment17
Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomas16
OC43 - Radiogenomics pilot study in adrenocortical carcinoma: assessing the relationship between genetic background and computerized tomography texture16
Uterine changes in transgender men receiving testosterone therapy16
Gonadal tumor development in 46,XX disorders of gonadal development16
Mild hyponatremia in hospitalized patients: revisiting bone turnover and clinical implications16
The not-so-shortcomings of seated saline suppression testing in primary aldosteronism16
Distribution, severity, and management of joint pain in patients with acromegaly16
Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease16
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients16
Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ)16
Retraction of: Comparison of finasteride versus flutamide in the treatment of hirsutism16
Role of genetics in the age-related testosterone decline in men: a UK Biobank study16
Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-centre cross-sectional analysis15
Quality of life in patients with overt hypothyroidism: a systematic review15
Correction to: Somapacitan in children born small for gestational age: a multi-centre, open-label, controlled phase 2 study15
Primary hyperparathyroidism induces erythropoietin resistance through fibroblast growth factor 2315
Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea15
Hyperandrogenaemia, polycystic ovary syndrome, and physical fitness in women—a Northern Finland birth cohort study15
Saline suppression testing-induced hypocalcemia and implications for clinical interpretations15
HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis15
PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas15
Sex-specific effect of maternal thyroid peroxidase antibody exposure during pregnancy on 5- to 6-year-old children's cardiometabolic risk score: the Ma'anshan birth cohort study15
OC54 - Role of steroid hormone-binding proteins on the bioactivity of 11-oxygenated androgens14
NF1gene inactivation acts as a tumor driver inRET/RAS-negative medullary thyroid carcinomas14
Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study14
OC55 - The role of obstructive sleep apnea syndrome and continuous positive airways pressure therapy in the functional hypogonadism of male patients with severe obesity14
Pituitary apoplexy and SARS-CoV-2 infection: we need to look beyond the acute phase14
OC38 - Prevalence and predictors of testicular adrenal rest tumors in adults with congenital adrenal hyperplasia14
Impact of GH administration on skeletal endpoints in adults with overweight/obesity14
Hypoxia signaling pathway activation in osteoblasts suppresses osteocalcin production but does not alter male fertility in mice14
Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data13
Identifying factors associated with subsequent diagnosis of adrenal adenoma: a population-based historical case–control study13
Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy13
Pseudohypoxia and family history are key predictors of severe outcomes in hereditary pheochromocytoma and paraganglioma syndromes13
Therapeutic management of congenital forms of endocrine hypertension13
Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatment13
Obesity risk is associated with brain glucose uptake and insulin resistance13
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study13
Non-suppression of renin by renal cysts in a subset of patients with primary aldosteronism—a prospective observational single center study13
Target therapy forBRAFmutated anaplastic thyroid cancer: a clinical and molecular study13
Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules13
In-depth proteomic signature of parathyroid carcinoma13
EndoCompass project: research roadmap for calcium and bone endocrinology13
Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study13
Improving diagnosis in primary aldosteronism using HISTALDO and nodule size metrics13
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies13
OC20 - Effectiveness of bisphosphonates and denosumab on risk of vertebral fractures in prostate cancer patients under androgen-deprivation therapies: a real-world prospective study12
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity12
Adiposity rebound and height velocity in patients with congenital adrenal hyperplasia12
How to manage Cushing's disease after failed primary pituitary surgery12
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension12
Impact of remission status in endogenous Cushing's syndrome on cancer incidence12
Estimated global prevalence of genetic carriers of hereditary pheochromocytoma-paraganglioma syndrome in a large multiethnic genomic database12
P36 - Adavosertib-mediated wee1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models12
Subgroup analyses in clinical research: too tempting?12
Regulation of insulin expression and release in gene and cell therapy of insulin-deficient diabetes12
ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma12
KCNJ5 mutations in familial and non-familial primary aldosteronism12
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours12
OC42 - Ectopic Cushing's syndrome (ECS) - a diagnostic challenge. Differences between ECS and Cushing's disease (CD) - European Cushing's syndrome registry, ERCUSYN, Kraków12
Sexual dimorphism in benign adrenocortical tumours12
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis12
Diagnostic yield of genetic testing in children with short stature: a systematic review12
Association between premature ovarian insufficiency and biological aging12
Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition11
Gonadotropic status in adult women with pituitary stalk interruption syndrome11
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial11
European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause11
OC03 - [18F] Fluorethyltyrosine positron emission tomography in corticotroph pituitary adenomas11
Biomarkers for subtype stratification in primary aldosteronism: current and future perspectives11
Femora of women with premature ovarian insufficiency exhibit reduced strength and misalignment with the transmitted vertical forces from the upper body11
IGF-I assay methods and biologic variability: evaluation of acromegaly treatment response11
Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial11
Testicular volume in 268 children and adolescents followed-up for childhood obesity—a retrospective cross-sectional study11
Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota11
EJE Prize 2023: genes on steroids—genomic control of hepatic metabolism by the glucocorticoid receptor11
Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome11
Normal thyroid volume and goitre diagnosis on ultrasonography is population-sensitive11
Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis11
Sex steroids and androgen biomarkers in the healthy man study: within-person variability and impact of fasting11
Correction to: Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis11
Fetal growth restriction inhibits childhood growth despite catch-up in discordant identical twins: an observational cohort study11
Adrenal–adipose tissue crosstalk in health and disease11
Serum steroid metabolome dynamics in infancy: a longitudinal cohort study of healthy infants11
Association of menopausal hormone therapy with risk of cardiovascular disease in Korean women11
OC11 - Calcitonin levels in patients with chronic kidney disease: a retrospective monocenter observational study11
P21 - Exploring microvascular changes in the bulbar conjunctiva of patients with type 1 diabetes11
Endocrine and metabolic late effects in childhood cancer survivors in Germany: the VersKiK study11
Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease – a cross-sectional study11
Response to commentary: strengthening endocrinology training: integrating nonclinical competencies, patient, and trainee perspectives for better implementation strategies10
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain10
The power of sample size calculations10
Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature10
The efficacy of a harm reduction intervention for androgen abuse: a historically controlled trial10
Increased Risk of Atrial Fibrillation and Flutter in Patients with Cushing syndrome: A Population-Based Matched Cohort Study.10
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study10
Insulitis in human type 1 diabetes: lessons from an enigmatic lesion10
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma10
Inhaled glucocorticoid-induced metabolome changes in asthma10
Assessing the utility of aldosterone suppression testing for primary aldosteronism: time to move forward10
Differential cardiovascular risks of menopausal hormone therapy: insights from a Korean cohort10
Progression of acromegalic joint and psychological complications according to sex, treatments, and disease control10
Clinical and imaging presentations are associated with function in incidental adrenocortical adenomas: a retrospective cohort study10
The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology10
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations10
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma10
Congenital hypogonadotropic hypogonadism in a patient with a de novoPOGZmutation10
Gene expression profiling of subcutaneous adipose tissue reveals new biomarkers in acromegaly10
Re-evaluating GLP-1 receptor agonist-associated changes in copeptin10
IGF–PAPP-A–stanniocalcin axis and androgenic anabolic steroid use in men and women10
Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide–dependent Cushing's syndrome10
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis10
Diurnal cortisol features with cardiovascular disease in hypertensive patients: a cohort study10
Use of total calcium in hypoparathyroidism: a pragmatic approach but with limitations9
Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults9
Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice—an European Cooperative Study Group for Paediatric Rare Tumours survey9
Ketone supplementation acutely lowers androgen and glucose levels in women with polycystic ovary syndrome: a randomized clinical trial9
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire9
OC15 - A novel synergistic approach: indocyanine green-based photodynamic therapy combined with docetaxel for papillary thyroid cancer treatment9
Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring9
Accelerated MEN2A in homozygous RET carriers in the context of consanguinity9
Circulating immune profiles in ACTH-dependent Cushing's syndrome9
The association between body image and well-being in polycystic ovary syndrome: a mixed-methods study9
Author reply to comments by Wang et al. regarding “Musculoskeletal disease in acromegaly—a population-based registry study”9
Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patients9
Rare ZMPSTE24 variants increase risk of hypertriglyceridemia and metabolic syndrome9
Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia9
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial9
Retraction of: Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study9
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome9
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia9
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes9
OC44 - Therapeutic potential of adavosertib (AZD1775), a WEE1 kinase inhibitor, in advanced adrenocortical carcinoma: focus on molecular changes9
Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study9
Dynamic changes in LH/FSH ratios in infants with normal sex development9
Real-world outcomes of finerenone in primary aldosteronism9
P18 - A new LC-MS/MS method for the determination of serum cortisol, cortisone, and dexamethasone: utility in the interpretation of the low-dose dexamethasone suppression test9
Letter to the editor: sociodemographic, lifestyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses9
Real-life clinical impact of a five-tiered classification of pituitary tumors9
Pancreas transplantation today: quo vadis?9
Self-management and hospitalization in 615 Swedish patients with Addison's disease during the coronavirus disease 2019 pandemic: a retrospective study8
Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disorders8
Genetics and clinical characteristics of Korean patients with bilateral macronodular adrenocortical disease8
P37 - Correlation between seminal testosterone and cortisol and semen parameters in normozoospermic and teratozoospermic men8
Potential mechanisms of the glucocorticoid withdrawal syndrome8
Natural history of nonfunctioning pituitary microadenomas: a systematic review and individual participant data meta-analysis8
EndoCompass project: research roadmap for pituitary and neuroendocrine tumor endocrinology8
OC49 - Phenotypic transformation of a non-functioning pancreatic neuroendocrine tumour to a hormonally active insulinoma8
Addition of testosterone to endocrine care for transgender women: a dose-finding and feasibility trial8
Survival probabilities in patients with ectopic Cushing's syndrome—a systematic review and a single-arm meta-analysis8
Prolonged adrenocortical blockade following discontinuation of Osilodrostat8
OC57 - A multinational observational study on the clinical characteristics and treatments offered to women with polycystic ovary syndrome (PCOS)-related skin conditions presenting to specialist clinic8
The association of selective serotonin reuptake inhibitors and venlafaxine with profound hyponatremia8
0.15505290031433